Find an expert

Dr Moni holds a PhD in Artificial Intelligence & Data Science in 2014 from the University of Cambridge, UK followed by postdoctoral training at the University of New South Wales, University of Sydney Vice-chancellor fellowship, and Senior Data Scientist at the University of Oxford. Dr Moni then joined UQ in 2021. He also worked as an assistant professor and lecturer in two universities (PUST and JKKNIU) from 2007 to 2011. He is an Artificial Intelligence, Computer Vision & Machine learning, Digital Health Data Science, Health Informatics and Bioinformatics researcher developing interpretable and clinical applicable machine learning and deep learning models to increase the performance and transparency of AI-based automated decision-making systems.

His research interests include quantifying and extracting actionable knowledge from data to solve real-world problems and giving humans explainable AI models through feature visualisation and attribution methods. He has applied these techniques to various multi-disciplinary applications such as medical imaging including stroke MRI/fMRI imaging, real-time cancer imaging. He led and managed significant research programs in developing machine-learning, deep-learning and translational data science models, and software tools to aid the diagnosis and prediction of disease outcomes, particularly for hard-to-manage complex and chronic diseases. His research interest also includes developing Data Science, machine learning and deep learning algorithms, models and software tools utilising different types of data, especially medical images, neuroimaging (MRI, fMRI, Ultrasound, X-Ray), EEG, ECG, Bioinformatics, and secondary usage of routinely collected data.

• I am currently recruiting graduate students. Check out Available Projects for details. Open to both Domestic and International students.

Dr Moniruzzaman is working as a Senior Postdoctoral Research Fellow at the UQ Faculty of Medicine and PA Hospital of Metro South Health. His research focuses on the molecular pathobiology of inflammatory diseases, in particular, how mucosal epithelial cells and gut microbiota regulate immune function in the gastrointestinal (GI) tract and contribute to different diseases, including inflammatory bowel diseases (IBD) and functional GI symptoms called disorders of gut-brain interactions (DGBI). Dr Moniruzzaman received his PhD from The University of Queensland in 2020, where he studied how the interleukin(IL)-20 family of cytokines (IL-20, IL-22, and IL-24) regulate mucosal epithelial and immune function in inflammatory and infectious diseases, including ulcerative colitis (UC) and respiratory syncytial virus. After graduation, he received postdoctoral training in the IBD Lab at Mater Research Institute – UQ and Nanomedicine Lab at UQ School of Pharmacy, where he investigated the role of cannabinoid receptors in UC and colitis-associated colorectal cancer, development of cannabinoid formulations to treat UC, and involvement of autophagy gene Atg7 in 6-Thioguanin mediated protection from UC. He was awarded a highly competitive UQ Postdoctoral Research Fellowship (2021-2022) and UQ School of Pharmacy Strategic Grant (2022) to study cannabinoids and Atg7 in UC, Translational Research Institute LINC Grant (2023) to study cannabinoids in palliative care of patients with advanced cancer, and Metro South Health SERTA (2024-2025) to study non-antibiotic treatment of SI dysbiosis in patients with DGBI. His current work focuses on how small intestinal dysbiosis controls the mucosal immune microenvironment and contributes to the pathogenesis of DGBI, including irritable bowel syndrome (IBS), functional dyspepsia (FD), and gastroparesis.

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Prof Alina Morawska is Director of the Parenting and Family Support Centre, The University of Queensland. She is passionate about creating a world where children develop the skills, competencies and confidence to adapt and thrive in an ever-changing world. Her research focuses on the central role of parents in influencing all aspects of children’s development, and parenting interventions as a way of understanding healthy development, a means for promoting positive family relationships, and a tool for the prevention and early intervention in lifelong health and wellbeing. She has published extensively in the field of parenting and family intervention and has received numerous grants to support her research. She has been recognised as Australia’s top scholar in family studies.

Prof Karen Moritz is internationally renowned for her work in understanding how early life perturbations contribute to an increased risk of developing cardiovascular, renal and metabolic disease in adulthood. Over the last 5-7 years, her research has focused on determining how prenatal alcohol can result in “developmental programming” of disease. Her research has identified critical windows of susceptibility to alcohol, including the period around conception and prior to implantation. In addition, her work has identified the placenta as playing a key role in the sex-specific offspring outcomes following maternal perturbations. Her research spans both preclinical and clinical domains, highlighted by her appointment as the Director of the Child Health Research Centre in 2016.

Current projects are:

• Periconceptional alcohol exposure: Programming long-term health in offspring (with Dr Lisa Akison and Dr James Cuffe)

• Emerging therapies for diabetes and complications: Effects on metabolic, cardiovascular and renal function (with Dr Linda Gallo)

• Effect of prenatal insults on the developing placenta (with Dr Marloes Nitert Dekker, Prof Vicki Clifton [Mater], Dr David Simmons and Dr James Cuffe)

• Effect of prenatal insults on the developing kidney and implications for adult disease (with Dr Peter Trnka [QLD Children's Hospital])

• Impact of maternal cannabis and alcohol around conception on development and long-term health of offspring (with Dr David Simmons and Dr Lisa Akison)

Prof Moritz maintains a strong commitment to teaching of students, including lectures and research student supervision in undergraduate programs, supervision of Honours students and supervision of higher degree research students.

Dr Philip Mosley studied at the University of Oxford and obtained a masters degree in physiological sciences and a degree in medicine. He was also captain of the university boxing team and was awarded two full 'Blues'. He worked as a junior doctor in Manchester before moving to Australia to complete his specialist training in psychiatry.

Dr Mosley is a Fellow of the Royal Australian and New Zealand College of Psychiatry (RANZCP) and has completed an advanced certificate in Consultation-Liaison Psychiatry. As part of his training he also undertook a 2-year neuropsychiatry fellowship at the Royal Brisbane and Women’s Hospital (RBWH) and the Asia-Pacific Centre for Neuromodulation (APCN) at the University of Queensland. Currently, Dr Mosley works as a member of the deep brain stimulation (DBS) team at St Andrew's War Memorial Hospital, Brisbane, runs a private neuropsychiatry practice and also provides a consultation-liaison psychiatry service to the neurology, medical and surgical wards. Dr Mosley's private practice is focussed on neurodegenerative disease, movement disorders and head injury.

Dr Mosley is an active clinician-scientist with appointments at the QIMR Berghofer Medical Research Institute, Queensland Brain Institute and CSIRO. He completed his PhD in neuroscience in 2019 under the supervision of Professor Michael Breakspear. He published eleven peer-reviewed manuscripts and received the UQ Dean's Award for outstanding thesis. Dr Mosley has been the chief investigator in a study of the neuropsychiatric effects of DBS for Parkinson’s disease, in a study of medicinal cannabis for Tourette’s syndrome, a lead investigator in a clinical trial of DBS for obsessive-compulsive disorder and anorexia nervosa, as well as a clinical fellow in a neuroimaging study of Alzheimer’s disease. He has won prizes from the RANZCP in Old Age Psychiatry and Consultation-Liaison Psychiatry, and he has received research funding from the RBWH Foundation, the RANZCP Young Investigator Grant, Parkinson’s Queensland and Wesley Medical Research. Dr Mosley was awarded an ‘Advance Queensland’ Early Career Fellowship for his Parkinson's disease research and won the postgraduate medal from the Australian Society for Medical Research for findings arising from this project. In 2020, he won the Early Career Psychiatrist award from the RANZCP, which is presented to the fellow producing the most significant piece of research in the five years since fellowship. Currently Dr Mosley's research is funded by the National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund.

If you wish to contact Dr Mosley regarding a clinical matter, please do so via his neuropsychiatry clinic (Neurosciences Queensland) telephone: 07 3839 3688 or email: admin@nsqld.com.au.

Bryan is a graduate in medicine from the University of Queensland and holds a BA (Hons) degree in philosophy from the University of Western Australia. A medical specialist in psychiatry, he is a clinician researcher, who is Conjoint Professor at the Queensland Brain Institute, University of Queensland, and Director of Genetics at the Queensland Centre for Mental Health Research. His primary research interest is the molecular genetics of schizophrenia, and holds a MD degree (University of Queensland) in this field. Since 1990, he has conducted studies, with national and international collaborators, to identify susceptibility genes for this disorder. He is the recipient of grants from the Australian NHMRC and the US NIMH.

The primary research goal is to identify and functionally characterise susceptibility genes for schizophrenia and related disorders. A special focus is on the study of large collaborative samples and ethnically homogeneous populations. Key methodologies used in the lab include genome-wide association studies, next-generation sequencing, transcriptome profiling of post-mortem brain samples, neurocognitive and neuroimaging phenotyping and induced pluripotent stem cells.

Current areas of interest include pharmacogenomics of clozapine treatment response, whole exome sequencing focused on de novo mutations, and the neuroimmunology of schizophrenia

Dr Moyle’s laboratory (www.moylelab.com) uses cutting edge technologies for the synthesis of peptides, protein expression, and protein semi-synthesis to gain insights into the functional roles played by various biochemical pathways, to engineer better protein and peptide therapeutics, and to improve the delivery characteristics of various therapeutic molecules. Specific current areas of interest are detailed below:

1. Subunit Vaccine Development: methods to develop improved vaccines through the combination of recombinant and synthetic approaches to improve immunopotency and tailor immune responses (links to reseach articles on semisynthetic vaccines and peptide vaccines; reviews on vaccine development).
2. Delivery Systems for Nucleic Acid-Based Molecules: multi-component synthetic and recombinant approaches to improve the cellular uptake, and targeted delivery of various oligonucleotide molecules (e.g. siRNA, mRNA, pDNA and CRISPR-Cas9) as an exciting approach to treat or prevent various diseases (links to research articles and reviews).
3. Deciphering the Roles of Post-Translational Modifications: The combination of peptide synthesis and protein semisynthesis to enable the production of large amounts of site-specifically modified species, that can be used to deconvolute the roles played by various post-translational modifications (links to research articles).
4. Peptide/Protein Drugs and Delivery: The study of methods to improve the delivery characteristics of peptide/protein drugs (e.g. poor oral absorption, instability to chemical/enzymatic degradation, and the inability to reach their site/s of action) through chemical engineering approaches.
5. New Approaches for Superbugs: the development of antivirulence approaches, and formulations (e.g. various types of nanoparticles - silver, protein, mesoporous silica), which reduce the ability for microbes to cause disease, and make them more readily treated with antimicrobials, by providing access to synergistic combinations, and reducing the risk of antimicrobial resistance.

Information for Potential Students:

The Moyle lab considers applications from potential students and postdoctoral fellows with an interest in: i) infection control (including subunit vaccine and antimicrobial development); ii) delivery systems for peptide therapeutics; iii) targeted delivery systems; iv) studying the function of posttranslational modifications; and v) delivery systems for nucleic acid-based therapeutics (e.g. siRNA, shRNA, miRNA, mRNA, pDNA and CRISPR-Cas9). If you are interested in working in any of these areas please feel free to contact Dr Moyle (p.moyle@uq.edu.au). Please ensure that you supply an up to date CV; describe why you would like to work in the Moyle lab; provide a listing of publications (preferably with impact factors and citation counts); and indicate what skills you would bring to the lab. Detailed information on our laboratory is available at www.moylelab.com. Preference will be given to students and postdoctoral fellows who have their own funding.

Dr Moyle Biosketch:

Dr Moyle (H-index 30, >2600 citations; >95 publications; 13/8/2024; Google Scholar, ORCID, ResearcherID, and Publons profiles) received a PhD (Dec 2006) and a Bachelor of Pharmacy (Hons I) (Dec 2001) from The University of Queensland (UQ); graduated from the Pharmaceutical Society of Australia pre-registration pharmacist-training course (Nov 2002); and is registered with the Pharmacy Board of Australia. He currently works as an Associate Professor in the UQ School of Pharmacy, where he has been based since 2014.

Dr Moyle works in the fields of medicinal chemistry, chemical biology, and drug formulation, investigating subunit vaccine development, outcomes associated with histone post-translational modifications, and methods to improve the delivery characteristics of oligonucleotide (e.g. siRNA and pDNA), peptide, and protein therapeutics. During his PhD, Dr Moyle developed methods that enabled the synthesis of pure, lipid adjuvanted peptide vaccines, using advanced chemical ligation techniques. In addition, the conjugation of mannose to combined prophylactic/therapeutic human papillomavirus type-16 vaccines, to target dendritic cells, was demonstrated to significantly improve vaccine anti-tumour activity. This work, conducted with leading researchers at the QIMR Berghofer Medical Research Institute (Prof Michael Good & Dr Colleen Olive), established Dr Moyle’s national and international profile in the field of vaccine development, resulting in 11 peer reviewed papers, including top journals in the field (J Med Chem; J Org Chem), as well as 6 review articles and 2 invited book chapters.

Dr Moyle undertook his postdoctoral training in the laboratory of one of the world’s premier chemical biologists, Professor Tom Muir (the Rockefeller University, NY, USA; now at Princeton University, NJ, USA). During this time he developed an extensive knowledge of techniques for protein expression, bioconjugation, bioassays, and proteomics, which represent an essential skill set required for this proposal. As part of this work, Dr Moyle developed novel synthetic routes to generate site-specific ADP-ribose conjugated peptides and proteins. This research was hailed as a major breakthrough in the field, leading to several collaborations, and an exemplary publication in the prestigious chemistry journal JACS. This vast body of work identified the enzyme (PARP10) responsible for mono-ADP-ribosylation of histone H2B, and demonstrated interactions between this modification and several proteins, including BAL, which is associated with B cell lymphomas. In addition, a number of robust chemical methods were developed to enable the synthesis of a complete library of methyl-arginine containing histones, which were incorporated into synthetic chemically-defined chromatin to investigate the site-specific effects of arginine methylation on histone acetylation. This work led to a collaboration with colleagues at Rockefeller to investigate the effects of histone arginine methylation on transcription.

Teaching:

Dr Moyle teaches into the following subjects in the UQ School of Pharmacy.

• PHRM3011 (Quality Use of Medicines) - course coordinator
• PHRM4021 (Integrated Pharmaceutical Development)
• PHRM3021 (Dosage Form Design)
• PHRM2040 (Drug Discovery)

Awards:

2016 - Health and Behavioural Sciences (HABS) faculty commendation for Early Career Citations for Outstanding Contributions to Student Learning (ECCOSL)

2015 - ChemMedChem top 10 cited article of 2013 (link)

2014 - Highest ranked NHMRC development grant (2013; APP1074899)

2013 - Institute for Molecular Biology (IMB) Division of Chemistry and Structural Biology Prize

My current appointment is Director of Kidney Services at Redland Hospitals in Metro South, Brisbane, where I practice as a senior consultant nephrologist.

My research interests are varied and include post-transplant anaemia and iron metabolism, and novel measures of iron status such as hepcidin; improving dialysis outcomes though the implementation of evidence-based guidelines; kidney disease due to thrombotic microangiopathy (particularly aHUS) and the role of inhibitors of the complement system in kidney disease; and the use of honey to prevent infections in dialysis patients.

I am committed to teaching medical students and young nephrologists, and am actively involved in medical education at all levels.

Professor Craig Munns is the Mayne Professor of Paediatrics and Director of the Child Health Research Centre, The University of Queensland. Professor Munns is also a Senior Medical Officer in Paediatric Endocrinology and Diabetes at Queensland Children’s Hospital. He graduated from The University of Queensland, before training in paediatrics and endocrinology at The Royal Children’s Hospital, Brisbane. Professor Munns completed his PhD in paediatric growth disorders through UQ. He then undertook a post-doctoral fellowship in paediatric genetic bone disorders at The Shriners Hospital for Children, Montreal, Canada. From 2004 to 2021, Prof Munns was Senior Staff Specialist in Genetic and Metabolic Bone Disorders and Paediatric Endocrinologist at The Children’s Hospital at Westmead, Sydney. He also undertook roles as Clinical Program Director, Division of Diagnostic Services and Clinical Trials Lead at Kids Research. As Clinical Trials Lead his focus was on developing a research-intensive health system and introducing advanced therapeutics.

Professor Munns is an international expert in paediatric musculoskeletal disorders. His primary clinical and research interests are in diagnosis and management of primary and secondary bone disorders, including osteogenesis imperfecta, hypophosphataemic rickets, disuse osteoporosis and nutritional rickets. He has undertaken a wide range of investigator initiated and sponsored clinical trials, authored international consensus documents and has supervised numerous PhD and Masters students. Prof Munns is actively involved in national and international scientific societies. He was treasurer of Asia Pacific Paediatric Endocrine Society, is the inaugural treasurer of the International Society of Children’s Bone Health and has chaired the program organising committees Australasian Paediatric Endocrine Group, Australian and New Zealand Bone and Mineral Society and International Conference of Children’s Bone Health.

I am a cultural anthropologist with expertise in gender, racism, medical anthropology, and critical global health. I have conducted extensive ethnographic research in Indonesia on health care, gendered violence, education, and racial stigma. The main focus of my research is Papua/West Papua, where my work has tried to document and understand evolving forms of racism and violence, including how people resist and create change. Over the past 15 years I have worked with local Papuan and international research teams on studies of violence, older women's life stories, HIV/AIDS, hospital birth, and health vulnerabilities. My research aims to develop knowledge of the nuances and complexities of conditions and experiences in West Papua, while also working with Papuan scholars and community members to address pressing health and social problems.

I recently completed a study with Els Tieneke Rieke Katmo and Meki Wetipo on how urban Papuans today understand and experience pregnancy and childbirth and how hospital childbirth may be creating more distrust in the health system rather than improving maternal health (2023, The Asia Pacific Journal of Anthropology), published as part of a special issue on 'Reproducing Life in Conditions of Abandonment in Oceania', edited with Sandra Widmer. Another recent multi-sited study looks at vulnerabilities in Indonesia with Professor Lyn Parker (University of Western Australia) and others from the UK and Indonesia. The study used ethnography and surveys to develop a deeper, contextual understanding of who is vulnerable, how and why, and thus shed light on the concept of vulnerability and what it means. Forthcoming publications look at education in Indonesia's frontier economy, older women’s narratives of economic agency and survivance (co-authored with Yohana Baransano), and the challenges faced by newlyweds.

I am expanding my research with older Papuan women on their experiences of the late Dutch and early Indonesian era and their narratives of survivance to include Papuan women from different cultural backgrounds and urban/rural locations. Papuan women's stories and historical experiences are largely missing from public view but are needed to understand their important contributions to society and their roles in creating the future. I am also expanding my research on obstetrics and c-sections to understand the cultures of maternity care in Indonesia, both in terms of local cultural needs and preferences, and in relation to the cultures of medicine and obstetrics that exist in hospitals and birth centres. This will help us to understand how to create respectful maternity care in different cultural contexts, including in Australia. Related to this, I recently completed an action research project funded by the Australia Indonesia Institute (with Els Katmo) on co-designing cultural approaches to sexual and reproductive health, including HIV prevention, in West Papua.

Some recent publications that illustrate key themes of my research:

Jenny Munro, Els Tieneke Rieke Katmo & Meki Wetipo (2022) Hospital Births and Frontier Obstetrics in Urban West Papua, The Asia Pacific Journal of Anthropology, 23:4-5, 388-406, DOI: 10.1080/14442213.2022.211512

Jenny Munro & Yohana Baransano (2023), From saving to survivance: Rethinking Indigenous Papuan women's vulnerabilities in Jayapura, Indonesia. Asia Pacific Viewpoint https://doi.org/10.1111/apv.12367

Jenny Munro, Lyn Parker, and Yohana Baransano. "There's Money but No Work": Diploma Disruptions in Urban Papua. The Contemporary Pacific 33, no. 2 (2021): 364-384.

Jenny Munro (2020) Global HIV Interventions and Technocratic Racism in a West Papuan NGO, Medical Anthropology, 39:8, 704-719, DOI: 10.1080/01459740.2020.1739036

Jenny Munro. (2020), ‘Saving our people’: health workers, medical citizenship, and vernacular sovereignties in West Papua. Journal of the Royal Anthropological Institute 26: 633-651. https://doi.org/10.1111/1467-9655.13318

I am an experienced PhD supervisor in medical anthropology and gender studies. I am particularly interested in working with candidates who wish to study gender, health, or racism in (or in relation to) West Papua using anthropological, ethnographic and qualitative approaches. Research projects I have supervised include:

• Intersectionality in Australian domestic violence services
• Changing masculinities in Uzbekistan
• Gender and education in Enga province, Papua New Guinea
• Australian spiritual healing
• Household meat practices in Indonesia and Australia
• Women’s empowerment and energy in South Africa
• Health of Pacific seasonal workers in Queensland Australia
• Carers’ experiences with medicinal cannabis
• Apitherapy in Australia

I teach undergraduate and postgraduate courses on medical anthropology (ANTH2250/7250) and Pacific anthropology (ANTH2020). I also supervise Honours students and co-coordinate HHSS6002 (Honours coursework).

Beatrice is a Postdoctoral Researcher with a special interest in behaviour change and digital health promotion. She has extensive experience in clinical trial management and evaluation. Following on from a Master’s Degree in Medical Science, her PhD was dedicated to the development of a mobile app that targeted adults’ physical activity and sleep health. The body of work she has contributed to has incorporated a wide range of research methods and study designs and her research outputs have added important knowledge to the field of multiple behaviour change and non-clinical sleep interventions. In more recent roles, Beatrice has worked on wide-scale implementation projects targeting the health and wellbeing of young children. Beatrice’s work is about maximising impact, both in the scientific field and out in the community by way of generating high quality data and improving equity of access to evidence-based resources.

Associate Professor Muttenthaler is a medicinal chemist working at the interface of chemistry and biology with a strong passion for translational research. His research focuses on bioactive peptides and exploring Nature's biodiversity to develop advanced molecular tools, diagnostics, and therapeutics. His background in drug discovery and development, as well as his interdisciplinary training in the fields of chemistry, molecular biology and pharmacology, assist him in characterising these often highly potent and selective compounds to study their interactions with human physiology for medical innovations in pain, cancer, gut disorders and neurological diseases.

Dr. Pyi Naing is a dual-trained cardiologist and general physician with subspecialty expertise in Echocardiography. His clinical and academic interests include evaluation and management of breathlessness, pulmonary hypertension, chronic heart failure, cardiac risk assessment and valvular heart diseases.

His advanced cardiology training was at The Prince Charles Hospital, the premier cardiac hospital in Australia where he earned the fellowship of Royal Australian College of Physicians (FRACP) in cardiology. He continued his training as an echocardiography fellow at the same hospital and gained further skills in all aspects of echocardiography including transesophageal, transthoracic and stress echocardiography.

Dr Naing is also a well published clinical academic with an MPhil degree from University of Notre Dame, Australia. He is currently completing a Ph.D. degree by studying novel methods to improve the care for breathless patients. He holds a senior lecturer position at the School of Medicine, University of Queensland. He has public appointments in Caboolture Hospital and The Prince Charles Hospital as a consultant cardiologist. He is bilingual in Burmese and English.

Soumyalekshmi Nair has a degree in Veterinary and Animal Sciences (2009) and a Master of Veterinary Science in Animal Biotechnology (2011) from India. She completed her PhD in 2021 from the Faculty of Medicine, the University of Queensland. In her PhD she investigated the role of extracellular vesicles in gestational diabetes mellitus which involves developing extracellular vesicle -based biomarker for the early screening of pregnant women as well as therapeutic targets for the treatment of women with gestational diabetes. She was awarded the Research Training Scholarship from the University of Queensland and received prestigious awards from the Society of Reproductive Investigation and Australian and New Zealand Society for Extracellular Vesicles. Currently she is a Postdoctoral Research Fellow at the Exosome Biology Lab, UQ Centre for Clinical Research (UQCCR). Her research interest is understanding the molecular mechanism by which extracellular vesicles can regulate the key signalling pathways in diseases such as obesity, diabetes, and ovarian cancer, with a focus on translating this knowledge into clinical utility. She has several key publications in the field including research articles and reviews and presented at major national and international conferences. She is passionate about supporting women in science and enhancing community engagement in Science, Technology, Engineering and Mathematics (STEM).

Dr. Bushra Nasir is the Director of the Medical Research Futures Fund in Primary Health Care Digital Innovations - ID-INSPIRED and a mid-career researcher with a substantial career trajectory in health research. Her expertise and instrumental involvement in multiple large-scale grants are demonstrated through numerous top-tier publications, media and news citations, and recognition in national and international policy documents. She has contributed to developing several global health policy recommendation publications, including a World Health Organisation review investigating the retention of the health workforce in rural and remote areas. Her contribution to this discipline is further substantiated by her peer-review activities and international and national collaborations with wide outreach and engagement initiatives.

Her collaborative networking qualities contribute to numerous roles in various research committees, including as a previous Chair of the Faculty of Medicine Early Career Researcher Committee. Her work has also resulted in increased research capacity building in regional and rural South East Queensland, supporting clinicians, medical students and educators, and other healthcare service providers conducting clinical and epidemiological research projects. She is also a research mentor and member of several national organisations. Her ongoing leadership, management, networking, and knowledge expertise, contribute to the progress of research practices with academics, experts, and clinical scientists.

Prof Nestor joined the Queensland Brain Institute in October/2017 and has a conjoint appointment as a cognitive neurologist at Mater Misericordiae Ltd (Mater Hospital).

His particular interests include understanding the earliest stages of Alzheimer's disease (i.e. before dementia is established); atypical forms of dementia with a particular focus on primary progressive aphasia and dementias related to Parkinson's and Lewy body diseases; and improving differential diagnosis between the major categories of neurodegenerative diseases.

He works on development of neuropsychological tests of cognition, both to accurately track change over time and improve diagnostic accuracy between the major diseases causing dementia. He also uses multi-modal imaging (magnetic resonance imaging [MRI] and positron emission tomography [PET]) to understand the sequence of events occurring in degenerative brain diseases (particularly Alzheimer's disease, frontotemporal dementia, Parkinson's disease, motor neuron disease [ALS], progressive supranuclear palsy [PSP] and corticobasal degeneration [CBD]) and identify novel biomarkers. A major focus of his is on developing novel approaches to MR imaging for single subject pathological diagnoses that can be exported into the everyday clinical setting; recent examples include diffusion tensor imaging to identify PSP and CBD (Sajjadi et al, 2013) and quantitative susceptibility mapping in Parkinson's disease (Acosta-Cabornero et al, 2013).